Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arthroleve ULT
- Development stage
- Unknown
- Lead developer
- Healthdirect Australia
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Arthroleve ULT is a multi-ingredient dietary supplement formulated to promote joint health, flexibility, and comfort. It features a synergistic blend of glucosamine sulfate, chondroitin sulfate, and methylsulfonylmethane (MSM), which serve as essential structural components or precursors for the synthesis of joint cartilage and connective tissue. The formulation is enhanced with botanical extracts, including *Boswellia serrata* and curcumin, which provide anti-inflammatory support by inhibiting key enzymatic pathways such as 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2). Additionally, the inclusion of hyaluronic acid supports synovial fluid viscosity and joint lubrication. Developed for individuals experiencing joint discomfort or symptoms of osteoarthritis, Arthroleve ULT aims to maintain joint integrity and mitigate systemic inflammation through a combination of structural reinforcement and biochemical modulation.
- Brand names
- Arthroleve ULT
- Other names
- Arthroleve UltimateArthroleve Ultimate Joint Support
02
Targets
NF-κBIL1B (Interleukin-1 beta)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on Arthroleve ULT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arthroleve ULT.